UnitedHealth Group (UNH) Fundamental Analysis: Revenue, Earnings & Valuation

6.17 / 10

Outperform

Fundamentally, UNH receives an Outperform rating with a 6.2/10 score. Strengths include rising cash, strong operating cash flow per share, and EPS growth. Caution arises from Revenue‑MV and PB‑ROE metrics, which lag peers. Overall outlook remains positive.

Analysis Checks(8/10)

Revenue-MV

Value1.84

Score1/3

Weight7.52%

1M Return3.16%

Net cash flow from operating activities per share (YoY growth rate %)

Value-17.81

Score3/3

Weight14.27%

1M Return5.35%

PB-ROE

Value-0.09

Score1/3

Weight-0.81%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value-15.09

Score3/3

Weight11.96%

1M Return4.72%

Total profit (YoY growth rate %)

Value-26.77

Score3/3

Weight12.87%

1M Return5.14%

Net cash flow from operating activities (YoY growth rate %)

Value-18.62

Score3/3

Weight14.55%

1M Return5.57%

Cash-UP

Value-1.53

Score2/3

Weight4.34%

1M Return1.89%

Diluted earnings per share (YoY growth rate %)

Value-14.70

Score3/3

Weight12.69%

1M Return5.00%

Asset-MV

Value-0.55

Score2/3

Weight17.22%

1M Return5.83%

Cash-MV

Value-1.31

Score2/3

Weight5.38%

1M Return2.13%

Is UNH undervalued or overvalued?

UNH scores 6.17/10 on fundamentals and holds a Discounted valuation at present. Backed by its 11.80% ROE, 2.86% net margin, 19.50 P/E ratio, 2.31 P/B ratio, and -15.09% earnings growth, these metrics solidify its Outperform investment rating.